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The recent coronavirus disease (COVID-19) pan-
demic had an immense effect on health systems
worldwide, which have had to deal with the chal-
lenge of simultaneously responding to the needs of
COVID-19 patients and managing other life-threat-
ening disorders. Several European countries such as
Italy, France and Spain, particularly hit by the pan-
demic, had to substantially reorganize healthcare
and redistribute personnel, resources and beds to
deal with the demand of the uncontrolled spread of
the COVID-19 infection [1]. Many stroke services
and teams were closed or reallocated, and different
stroke care pathways were implemented in many
countries, according to local health system resources
and organization [1]. Overall, these actions affected
standard stroke care, including the delivery of time-
dependent treatments and adequate diagnostic evalu-
ations [1,2].
In this issue of the European Journal of Neurology,
two papers report on stroke care changes during the
COVID-19 outbreak. In the first, Tejada Meza et al.
[3] show the impact of COVID-19 in the Aragon
region, Spain. Data on 275 patients admitted before
and 79 patients admitted during the COVID-19 per-
iod showed a significant drop in the number of hospi-
tal admissions for stroke and in the rate (8.5 vs. 4
per week) of reperfusion therapies (intravenous
thrombolysis or mechanical thrombectomy). The sec-
ond paper, by Pop et al. [4], reports an analysis of
the change of acute stroke pathway parameters
between March 2019 and March 2020 in three stroke
units of Alsace, France. A reduction of 39.5% in
stroke alerts (174 in 2020 vs. 288 in 2019) and of
33.3% in acute revascularization therapies was
observed. No delay in the onset-to-needle time was
reported in either study and no clinical and demo-
graphic difference between patients admitted in the
pre- and post-COVID era was shown. The two
papers highlight the importance of alert activation
measures to mitigate the impact of the COVID-19
outbreak on acute stroke care.
These two studies, although limited by a short
observation time, are among the first to report data
on stroke care quality changes in Europe at the time
of the COVID-19 pandemic. Although other observa-
tions on stroke care changes have been published,
most of them lack systemic information due to the
difficulty in data collection at this challenging time. A
decreased number of acute stroke admissions was reg-
istered in many countries despite there being no rea-
son to believe that the overall stroke incidence has
been different. This phenomenon is still unexplained.
One possible reason is that many patients with milder
stroke remained at home for the fear of infection in
the hospital or because symptoms were not clearly
recognized as a result of social isolation and lockdown
[2,3,5-7]. In other cases, stroke signs could be misdiag-
nosed in patients with COVID-19-associated severe
respiratory problems or because protection measures
and distancing limited or even prevented neurological
consultations. Although these two reports are related
to restricted geographical areas of Europe, their obser-
vations provide a warning about the negative impact
that COVID-19 has had on the quality of pre-hospital
and in-hospital stroke care and hint at possible long-
term consequences in terms of increased disability
burden. Because stroke is the second cause of mortal-
ity and the first cause of disability in Western coun-
tries, the best stroke care should be ensured, even in
challenging times, in order not to undo the excellent
results achieved over the last years in improving
stroke outcomes [5,8].
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